SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
KYMR

Kymera Therapeutics, Inc. (NASDAQ:KYMR)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
113.94+3.18 (+2.87%)
 
Market cap
$9.37B
Analyst consensus
Listed since
Aug 21, 2020
Insider Score
––Not scored
KYMR Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

KYMR Stock Insider Trading Activity

KYMR stock’s insider trading shows 24 sales on the open market for an estimated $28.58M by company insiders over the last 6 months.

Not enough price history.

Insider Trading Activity (Form 4 Filings)

An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.

Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
InsiderActionSharesAvg CostTotalΔ HoldingsHeld AfterDateGradeForm 4
Mainolfi Nello
CEO
Option exercise30,000$2.08$62.40K 4.5%696,568Oct 1, 2026— Form 4
Mainolfi Nello
CEO
Sell3,525$111.44$392.83K 0.5%693,043Oct 1, 2026— Form 4
Mainolfi Nello
CEO
Sell5,506$112.42$618.98K 0.8%687,537Oct 1, 2026— Form 4
Mainolfi Nello
CEO
Sell4,876$113.24$552.16K 0.7%682,661Oct 1, 2026— Form 4
Mainolfi Nello
CEO
Sell7,601$114.43$869.78K 1.1%675,060Oct 1, 2026— Form 4
Mainolfi Nello
CEO
Sell8,230$115.40$949.74K 1.2%666,830Oct 1, 2026— Form 4
Mainolfi Nello
CEO
Sell262$116.12$30.42K 0.0%666,568Oct 1, 2026— Form 4
Adams Brian
Other
Sell1,209$115.55$139.70K 2.1%55,416Sep 4, 2026— Form 4
Adams Brian
Other
Sell3,025$116.81$353.35K 5.5%52,391Sep 4, 2026— Form 4
Adams Brian
Other
Sell2,137$117.57$251.25K 4.1%50,254Sep 4, 2026— Form 4
Rooney Terence
Other
Award38,000—— New38,000Jul 27, 2026— Form 4
Mainolfi Nello
CEO
Option exercise50,000$2.08$104.00K 7.5%716,568Jul 7, 2026— Form 4
Mainolfi Nello
CEO
Sell50,000$119.00$5.95M 7.0%666,568Jul 7, 2026— Form 4
Goodman Noah
Other
Sell3,389$114.29$387.33K 6.7%47,179Jul 1, 2026— Form 4
Mainolfi Nello
CEO
Option exercise80,000$2.08$166.40K 12.0%746,568Jul 1, 2026— Form 4
Mainolfi Nello
CEO
Sell1,883$112.80$212.41K 0.3%744,685Jul 1, 2026— Form 4
Mainolfi Nello
CEO
Sell6,626$113.98$755.20K 0.9%738,059Jul 1, 2026— Form 4
Mainolfi Nello
CEO
Sell24,105$114.96$2.77M 3.3%713,954Jul 1, 2026— Form 4
Mainolfi Nello
CEO
Sell44,050$115.69$5.10M 6.2%669,904Jul 1, 2026— Form 4
Mainolfi Nello
CEO
Sell3,336$116.56$388.84K 0.5%666,568Jul 1, 2026— Form 4
Jacobs Bruce N.
CFO
Option exercise61,378$5.33$327.14K 23.6%321,992Jun 30, 2026— Form 4
Jacobs Bruce N.
CFO
Sell1,500$110.54$165.81K 0.5%320,492Jun 30, 2026— Form 4
Jacobs Bruce N.
CFO
Sell1,700$111.57$189.66K 0.5%318,792Jun 30, 2026— Form 4
Jacobs Bruce N.
CFO
Sell1,100$112.79$124.07K 0.3%317,692Jun 30, 2026— Form 4
Jacobs Bruce N.
CFO
Sell4,110$114.19$469.31K 1.3%313,582Jun 30, 2026— Form 4
Jacobs Bruce N.
CFO
Sell51,375$114.77$5.90M 16.4%262,207Jun 30, 2026— Form 4
Jacobs Bruce N.
CFO
Sell7,971$115.82$923.18K 3.0%254,236Jun 30, 2026— Form 4
Jacobs Bruce N.
CFO
Sell6,153$116.99$719.86K 2.4%248,083Jun 30, 2026— Form 4
Jacobs Bruce N.
CFO
Sell3,200$117.70$376.65K 1.3%244,883Jun 30, 2026— Form 4
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
  • Sell (S) — Open-market or private sale
  • Award (A) — Grant or award from the company, not a purchase
  • Option exercise (M) — Exercise or conversion of an exempt derivative
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.